Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-04-16 5:16 pm Sale | 13D | AILERON THERAPEUTICS INC N ALRN | Satter Muneer A | 830,466 4.900% | -186,567 (-18.34%) | View |
2024-03-05 4:30 pm Purchase | 13D | AILERON THERAPEUTICS INC N ALRN | Satter Muneer A | 1,017,033 5.900% | 9,545 (+0.95%) | View |
2024-02-09 4:00 pm Purchase | 13G | AKEBIA THERAPEUTICS INC AKBA | Satter Muneer A | 16,205,119 8.600% | 1,115,000 (+7.39%) | View |
2023-11-03 4:30 pm Purchase | 13D | AILERON THERAPEUTICS INC N ALRN | Satter Muneer A | 1,007,488 19.900% | 1,007,488 (New Position) | View |
2023-02-17 4:00 pm Purchase | 13D | Annexon Inc. ANNX | Satter Muneer A | 7,679,521 15.000% | 2,647,058 (+52.60%) | View |
2023-02-10 1:08 pm Purchase | 13G | AKEBIA THERAPEUTICS INC AKBA | Satter Muneer A | 15,090,119 8.200% | 1,225,789 (+8.84%) | View |
2023-02-10 1:04 pm Purchase | 13G | AADI BIOSCIENCE INC AADI | Satter Muneer A | 1,630,830 6.700% | 336,045 (+25.95%) | View |
2022-12-19 4:10 pm Purchase | 13G | AKEBIA THERAPEUTICS INC AKBA | Satter Muneer A | 13,864,330 7.500% | 10,797,287 (+352.04%) | View |
2022-10-04 4:01 pm Purchase | 13G | AADI BIOSCIENCE INC AADI | Satter Muneer A | 1,294,785 5.300% | 1,294,785 (New Position) | View |
2022-07-18 4:45 pm Purchase | 13D | Annexon Inc. ANNX | Satter Muneer A | 5,032,463 10.400% | 3,077,485 (+157.42%) | View |
2022-02-10 4:06 pm Unchanged | 13G | ASSEMBLY BIOSCIENCES INC. ASMB | Satter Muneer A | 2,227,500 4.700% | 0 (Unchanged) | View |
2021-11-12 4:03 pm Sale | 13D | AADI BIOSCIENCE INC AADI | Satter Muneer A | 374,785 1.790% | -5,247,050 (-93.33%) | View |
2021-02-12 07:03 am Unchanged | 13G | ASSEMBLY BIOSCIENCES INC. ASMB | Satter Muneer A | 2,227,500 6.700% | 0 (Unchanged) | View |
2021-02-12 07:01 am Sale | 13G | ALBIREO PHARMA INC. ALBO | Satter Muneer A | 0 0.000% | -832,000 (Position Closed) | View |
2021-02-12 07:00 am Purchase | 13G | Annexon Inc. ANNX | Satter Muneer A | 1,954,978 5.100% | 1,954,978 (New Position) | View |
2021-01-08 4:04 pm Purchase | 13D | AILERON THERAPEUTICS INC N ALRN | Satter Muneer A | 20,340,792 19.900% | 9,000,000 (+79.36%) | View |
2021-01-04 4:01 pm Purchase | 13G | ASSEMBLY BIOSCIENCES INC. ASMB | Satter Muneer A | 2,227,500 6.700% | 2,227,500 (New Position) | View |
2020-11-20 5:31 pm Unchanged | 13D | AADI BIOSCIENCE INC AADI | Satter Muneer A | 5,621,835 11.900% | 0 (Unchanged) | View |
2020-06-09 5:13 pm Purchase | 13D | AILERON THERAPEUTICS INC N ALRN | Satter Muneer A | 11,340,792 19.900% | 3,700,000 (+48.42%) | View |
2020-02-12 10:33 am Unchanged | 13G | ALBIREO PHARMA INC. ALBO | Satter Muneer A | 832,000 5.590% | 0 (Unchanged) | View |